FTC seeks public comment on Cardinal Health nuclear pharmacy sales to Patient Care Infusion
The FTC is seeking public comment on Cardinal Health’s application to sell its former nuclear pharmacy assets to Patient Care Infusion. Cardinal is required to sell these assets–located in Las Vegas, Albuquerque, and El Paso–under the 2011 settlement with the FTC for its acquisition of three nuclear pharmacies from Biotech.
Public comments on the sale will be accepted until March 26, 2012.
Source: FTC Press Release
Related Content: Reviving Competition in Healthcare Markets: The Use of Section 5 of the FTC Act (David Balto)
Featured News
UK Regulator Puts Brakes on £762 Million Logistics Merger Amid Competition Fears
Nov 3, 2024 by
CPI
Nvidia’s Acquisition of AI Startup Run.ai Faces EU Antitrust Review
Nov 3, 2024 by
CPI
Voters Across US to Decide on Landmark Gig Economy Issues on November Ballots
Nov 3, 2024 by
CPI
Court Gives Green Light to $110M Deal in Real Estate Commission Dispute
Nov 3, 2024 by
CPI
Mexico’s First-Ever Class Action Targets Pharma Giants for Price Fixing
Nov 3, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Remedies Revisited
Oct 30, 2024 by
CPI
Fixing the Fix: Updating Policy on Merger Remedies
Oct 30, 2024 by
CPI
Methodology Matters: The 2017 FTC Remedies Study
Oct 30, 2024 by
CPI
U.S. v. AT&T: Five Lessons for Vertical Merger Enforcement
Oct 30, 2024 by
CPI
The Search for Antitrust Remedies in Tech Leads Beyond Antitrust
Oct 30, 2024 by
CPI